A Desirability of Outcome Ranking Analysis of a Randomized Clinical Trial Comparing Seven Versus Fourteen Days of Antibiotics for Uncomplicated Gram-Negative Bloodstream Infection

被引:11
|
作者
Howard-Anderson, Jessica [1 ]
Dai, Weixiao [2 ,3 ]
Yahav, Dafna [4 ,5 ]
Hamasaki, Toshimitsu [2 ,3 ]
Turjeman, Adi [5 ,6 ]
Koppel, Fidi [7 ]
Franceschini, Erica [8 ]
Hill, Carol [9 ]
Sund, Zoe [9 ]
Chambers, Henry F. [10 ]
Fowler, Vance G. [9 ,11 ]
Boucher, Helen W. [12 ]
Evans, Scott R. [2 ,3 ]
Paul, Mical [7 ,13 ]
Holland, Thomas L. [9 ,11 ]
Doernberg, Sarah B. [10 ]
机构
[1] Emory Univ, Dept Med, Div Infect Dis, Sch Med, Atlanta, GA 30322 USA
[2] George Washington Univ, Biostat Ctr, Milken Inst, Sch Publ Hlth, Washington, DC USA
[3] George Washington Univ, Dept Biostat & Bioinformat, Milken Inst, Sch Publ Hlth, Washington, DC USA
[4] Beilinson Med Ctr, Rabin Med Ctr, Unit Infect Dis, Petah Tiqwa, Israel
[5] Tel Aviv Univ, Sackler Fac Med, Ramat Aviv, Israel
[6] Beilinson Med Ctr, Rabin Med Ctr, Dept Med E, Petah Tiqwa, Israel
[7] Inst Infect Dis, Rambam Hlth Care Campus, Haifa, Israel
[8] Univ Modena & Reggio Emilia, Clin Infect Dis, Modena, Italy
[9] Duke Clin Res Inst, Durham, NC USA
[10] Univ Calif San Francisco, Dept Internal Med, Div Infect Dis, San Francisco, CA USA
[11] Duke Univ, Med Ctr, Dept Med, Durham, NC 27710 USA
[12] Tufts Med Ctr, Div Geog Med & Infect Dis, Boston, MA USA
[13] Technion Israel Inst Technol, Fac Med, Haifa, Israel
来源
OPEN FORUM INFECTIOUS DISEASES | 2022年 / 9卷 / 06期
基金
美国国家卫生研究院;
关键词
antibiotics; desirability of outcome ranking; Gram-negative bacteremia; treatment duration; ANTIMICROBIAL RESISTANCE; DURATION;
D O I
10.1093/ofid/ofac140
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background Although a short course (7 days) of antibiotics has been demonstrated to be noninferior to a conventional course (14 days) in terms of mortality and infectious complications for patients with a Gram-negative bacterial bloodstream infection (GNB), it is unknown whether a shorter treatment duration can provide a better overall clinical outcome. Methods We applied a bloodstream infection-specific desirability of outcome ranking (DOOR) analysis to the results of a previously completed, randomized controlled trial comparing short versus conventional course antibiotic therapy for hospitalized patients with uncomplicated GNB. We determined the probability that a randomly selected participant in the short course group would have a more desirable overall outcome than a participant in the conventional duration group. We performed (1) partial credit analyses allowing for calculated and variable weighting of DOOR ranks and (2) subgroup analyses to elucidate which patients may benefit the most from short durations of therapy. Results For the 604 patients included in the original study (306 short course, 298 conventional course), the probability of having a more desirable outcome with a short course of antibiotics compared with a conventional course was 51.1% (95% confidence interval, 46.7% to 55.4%), indicating no significant difference. Partial credit analyses indicated that the DOOR results were similar across different patient preferences. Prespecified subgroup analyses using DOOR did not reveal significant differences between short and conventional courses of therapy. Conclusions Both short and conventional durations of antibiotic therapy provide comparable clinical outcomes when using DOOR to consider benefits and risks of treatment options for GNB. We retrospectively applied a desirability of outcome ranking analysis to a randomized controlled trial comparing short versus conventional durations of antibiotics for Gram-negative bacteremia. A short duration of antibiotics provided similar desirability of clinical outcomes as a conventional duration.
引用
收藏
页数:7
相关论文
共 26 条
  • [1] Seven vs Fourteen Days of Antibiotics for Gram-Negative Bloodstream Infection A Systematic Review and Noninferiority Meta-Analysis
    Lee, Todd C.
    Prosty, Connor J.
    Fralick, Michael
    Huttner, Angela
    Mcdonald, Emily G.
    Molina, Jose
    Paul, Mical
    Pinto, Ruxandra
    Rishu, Asgar
    von Dach, Elodie
    Yahav, Dafna
    Fowler, Rob
    Daneman, Nick
    JAMA NETWORK OPEN, 2025, 8 (03)
  • [2] Seven Versus 14 Days of Antibiotic Therapy for Uncomplicated Gram-negative Bacteremia: A Noninferiority Randomized Controlled Trial
    Yahav, Dafna
    Franceschini, Erica
    Koppel, Fidi
    Turjeman, Adi
    Babich, Tanya
    Bitterman, Roni
    Neuberger, Ami
    Ghanem-Zoubi, Nesrin
    Santoro, Antonella
    Eliakim-Raz, Noa
    Pertzov, Barak
    Steinmetz, Tali
    Stern, Anat
    Dickstein, Yaakov
    Maroun, Elias
    Zayyad, Hiba
    Bishara, Jihad
    Alon, Danny
    Edel, Yonatan
    Goldberg, Elad
    Venturelli, Claudia
    Mussini, Cristina
    Leibovici, Leonard
    Paul, Mical
    CLINICAL INFECTIOUS DISEASES, 2019, 69 (07) : 1091 - 1098
  • [3] The impact of previous hospitalization in the preceding 90 days on the outcome in critically ill patients with gram-negative bloodstream infection
    Zeng, Qiaojun
    Xu, Fengqin
    Jiang, Shanping
    DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2014, 80 (02) : 136 - 140
  • [4] Switch to oral antibiotics in Gram-negative bacteraemia: a randomized, open-label, clinical trial
    Omrani, Ali S.
    Abujarir, Sulieman H.
    Ben Abid, Fatma
    Shaar, Shahd H.
    Yilmaz, Mesut
    Shaukat, Adila
    Alsamawi, Mussad S.
    Elgara, Mohamed S.
    Alghazzawi, Mohamed Islam
    Shunnar, Khaled M.
    Zaqout, Ahmed
    Aldeeb, Yasser M.
    Alfouzan, Wadha
    Almaslamani, Muna A.
    CLINICAL MICROBIOLOGY AND INFECTION, 2024, 30 (04) : 492 - 498
  • [5] Intravenous to oral transition of antibiotics for gram-negative bloodstream infection at a University hospital in Thailand: Clinical outcomes and predictors of treatment failure
    Pradubkham, Titawadee
    Suwanpimolkul, Gompol
    Gross, Alan Edward
    Nakaranurack, Chotirat
    PLOS ONE, 2022, 17 (09):
  • [6] Duration of Antibiotic Therapy in Neonatal Gram-negative Bacterial Sepsis-10 Days Versus 14 Days A Randomized Controlled Trial
    Fursule, Anurag
    Thakur, Anup
    Garg, Pankaj
    Kler, Neelam
    PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2022, 41 (02) : 156 - 160
  • [7] RANDOMIZED CLINICAL-TRIAL OF AZTREONAM AND AMINOGLYCOSIDE ANTIBIOTICS IN THE TREATMENT OF SERIOUS INFECTIONS CAUSED BY GRAM-NEGATIVE BACILLI
    DEMARIA, A
    TREADWELL, TL
    SAUNDERS, CA
    PORAT, R
    MCCABE, WR
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1989, 33 (08) : 1137 - 1143
  • [8] 7 versus 14 days of antibiotic treatment for critically ill patients with bloodstream infection: a pilot randomized clinical trial
    Daneman, Nick
    Rishu, Asgar H.
    Pinto, Ruxandra
    Aslanian, Pierre
    Bagshaw, Sean M.
    Carignan, Alex
    Charbonney, Emmanuel
    Coburn, Bryan
    Cook, Deborah J.
    Detsky, Michael E.
    Dodek, Peter
    Hall, Richard
    Kumar, Anand
    Lamontagne, Francois
    Lauzier, Francois
    Marshall, John C.
    Martin, Claudio M.
    McIntyre, Lauralyn
    Muscedere, John
    Reynolds, Steven
    Sligl, Wendy
    Stelfox, Henry T.
    Wilcox, M. Elizabeth
    Fowler, Robert A.
    TRIALS, 2018, 19
  • [9] 7 versus 14 days of antibiotic treatment for critically ill patients with bloodstream infection: a pilot randomized clinical trial
    Nick Daneman
    Asgar H. Rishu
    Ruxandra Pinto
    Pierre Aslanian
    Sean M. Bagshaw
    Alex Carignan
    Emmanuel Charbonney
    Bryan Coburn
    Deborah J. Cook
    Michael E. Detsky
    Peter Dodek
    Richard Hall
    Anand Kumar
    Francois Lamontagne
    Francois Lauzier
    John C. Marshall
    Claudio M. Martin
    Lauralyn McIntyre
    John Muscedere
    Steven Reynolds
    Wendy Sligl
    Henry T. Stelfox
    M. Elizabeth Wilcox
    Robert A. Fowler
    Trials, 19
  • [10] Comparing Propensity Score Methods Versus Traditional Regression Analysis for the Evaluation of Observational Data: A Case Study Evaluating the Treatment of Gram-Negative Bloodstream Infections
    Amoah, Joe
    Stuart, Elizabeth A.
    Cosgrove, Sara E.
    Harris, Anthony D.
    Han, Jennifer H.
    Lautenbach, Ebbing
    Tamma, Pranita D.
    CLINICAL INFECTIOUS DISEASES, 2020, 71 (09) : E497 - E505